{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T11:42:01Z","timestamp":1725795721031},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,11,3]],"date-time":"2003-11-03T00:00:00Z","timestamp":1067817600000},"content-version":"vor","delay-in-days":2193,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1997,11]]},"abstract":"<jats:p>In the present study peripheral T cell tolerance and the occurrence of shock were evaluated in young and old mice after injection of Staphylococcal enterotoxin B (SEB). In young mice SEB immunization leads to tolerance based on deletion and anergy of SEB\u2010reactive V\u03b28<jats:sup>+<\/jats:sup>\u2003T cells. With aging, mice developed resistance to SEB\u2010induced deletion of V\u03b28<jats:sup>+<\/jats:sup>\u2003T cells as well as a high sensitivity to toxic shock. Compared to young mice, older mice injected with SEB showed increased serum levels of interferon\u2010\u03b3 (IFN\u2010\u03b3), interleukin\u20102 (IL\u20102) and IL\u20104. These results were confirmed by reverse transcription\u2010polymerase chain reaction (RT\u2010PCR), as splenic mRNA levels taken 2\u2003h after SEB injection showed higher values of IL\u20102, IL\u20104, and IFN\u2010\u03b3 in old mice. In contrast, mRNA levels for FasL and tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1) were lower. No difference in IL\u201010 mRNA was found. Compared to young mice, old mice showed a high, but statistically not significantly different (<jats:italic>P\u2003<\/jats:italic>=\u20030.20), production of nitric oxide (NO). Blocking of IFN\u2010\u03b3 with antibodies or reducing IFN\u2010\u03b3 by depletion of natural killer (NK) cells resulted, respectively, in a complete or partial protection against mortality in aged mice. Suppressing the NO production by the NO synthase inhibitor N\u2010nitro\u2010L\u2010arginine methylester (L\u2010NAME) increased the mortality in both young and old mice, and abrogated clonal deletion in the surviving young mice. In conclusion, in young mice NO production is a key factor in the protection against mortality and the development of clonal deletion after SEB injection. The higher mortality seen in older mice is mainly related to the elevated production of IFN\u2010\u03b3 and occurs despite a sufficient production of NO. The decreased clonal deletion of old mice may be related to their decreased expression of Fas ligand or TNF\u2010\u03b1 after SEB injection.<\/jats:p>","DOI":"10.1046\/j.1365-3083.1997.d01-153.x","type":"journal-article","created":{"date-parts":[[2003,11,3]],"date-time":"2003-11-03T20:43:25Z","timestamp":1067892205000},"page":"469-478","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased Mortality and Impaired Clonal Deletion After Staphylococcal Enterotoxin B Injection in Old Mice: Relation to Cytokines and Nitric Oxide Production"],"prefix":"10.1111","volume":"46","author":[{"given":"L. M.","family":"KUSCHNAROFF","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"GOEBELS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"VALCKX","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"HEREMANS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"MATTHYS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"WAER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,11,3]]},"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3083.1997.d01-153.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3083.1997.d01-153.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3083.1997.d01-153.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T10:54:01Z","timestamp":1694343241000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3083.1997.d01-153.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["10.1046\/j.1365-3083.1997.d01-153.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3083.1997.d01-153.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]},"assertion":[{"value":"2003-11-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}